SHC Sotera Health Co
Nasdaq · SEC CIK 1822479 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.59B 17 sales by 10 insiders
- Filings on record
- 114 since 2021-08-27, latest 2026-08-19 16:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| WARBURG PINCUS & CO. | Dir, 10% | — | $579.51M |
| Warburg Pincus Partners II, L.P. | Dir, 10% | — | $510.75M |
| Warburg Pincus Partners GP LLC | Dir, 10% | — | $387.78M |
| GTCR FUND XI/A LP | Dir, 10% | — | $293.62M |
| Warburg Pincus Private Equity XI-C, L.P. | Dir, 10% | — | $281.70M |
| GTCR INVESTMENT XI LLC | Dir, 10% | — | $193.17M |
| WARBURG PINCUS LLC | Dir, 10% | — | $158.73M |
| GTCR CO-INVEST XI LP | Dir, 10% | — | $152.70M |
| Petras Michael B. Jr. | Executive COB, Dir | — | $33.51M |
| Rutz Michael P | Pres of Sterigenics | — | $2.83M |
Transactions 131
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 16:24 | 2026-08-17 | SHC | Petras Michael B. Jr. | Executive COB, Dir | S - Sale | $18.50 | -294.5K | 397.9K | -43% | -$5.45M | |
| I | 2026-08-19 16:24 | 2026-08-17 | SHC | Petras Michael B. Jr. | Executive COB, Dir | S - Sale | $18.50 | -850.0K | 3.97M | -18% | -$15.73M |
| 2026-08-11 16:24 | 2026-08-07 | SHC | Rutz Michael P | Pres of Sterigenics | S - Sale | $18.84 | -150.0K | 334.3K | -31% | -$2.83M | |
| 2026-08-07 16:16 | 2026-08-05 | SHC | Lyons Jonathan M. | CFO, Sr. VP | F - Tax | $17.98 | -11.3K | 217.3K | -5% | -$203.5K | |
| 2026-05-27 20:27 | 2026-05-22 | SHC | Klee Ann R. | Dir | A - Grant | $0.00 | +15.0K | 140.9K | +12% | $0 | |
| DM | 2026-05-27 17:54 | 2026-05-26 | SHC | SHADER ALTON | CEO, Dir | A - Grant | $0.00 | +579.6K | 579.6K | New | $0 |
| 2026-05-27 17:43 | 2026-05-22 | SHC | Kyle Richard G | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| 2026-05-27 17:40 | 2026-05-22 | SHC | Krause Kenneth D. | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| 2026-05-27 17:38 | 2026-05-22 | SHC | CUNNINGHAM SEAN LAURENCE | Dir | A - Grant | $0.00 | +15.0K | 95.8K | +19% | $0 | |
| 2026-05-27 17:36 | 2026-05-22 | SHC | Flynn Karen | Dir | A - Grant | $0.00 | +15.0K | 54.2K | +38% | $0 | |
| 2026-05-27 17:28 | 2026-05-22 | SHC | Neary James | Dir | A - Grant | $0.00 | +15.0K | 95.8K | +19% | $0 | |
| 2026-05-27 17:25 | 2026-05-22 | SHC | PETRELLA VINCENT K | Dir | A - Grant | $0.00 | +15.0K | 95.8K | +19% | $0 | |
| 2026-05-27 17:23 | 2026-05-22 | SHC | Chen Ruoxi | Dir | A - Grant | $0.00 | +15.0K | 95.8K | +19% | $0 | |
| 2026-05-27 17:21 | 2026-05-22 | SHC | Simon, Christopher | Dir | A - Grant | $0.00 | +15.0K | 34.1K | +78% | $0 | |
| 2026-05-27 17:19 | 2026-05-22 | SHC | Wheadon David E. | Dir | A - Grant | $0.00 | +15.0K | 89.9K | +20% | $0 | |
| I | 2026-05-15 16:54 | 2026-05-13 | SHC | WARBURG PINCUS & CO. | Dir, 10% | S - Sale | $15.17 | -19.10M | 0 | -100% | -$289.75M |
| I | 2026-05-15 16:48 | 2026-05-13 | SHC | WARBURG PINCUS & CO. | Dir, 10% | S - Sale | $15.17 | -19.10M | 0 | -100% | -$289.75M |
| I | 2026-05-15 16:41 | 2026-05-13 | SHC | GTCR INVESTMENT XI LLC | Dir, 10% | S - Sale | $15.17 | -12.74M | 0 | -100% | -$193.17M |
| 2026-04-02 16:56 | 2026-03-31 | SHC | DIMITRIEF ALEXANDER | GC, Former SVP, Sec | F - Tax | $14.34 | -7,941 | 312.0K | -2% | -$113.9K | |
| I | 2026-03-10 | 2026-03-06 | SHC | Warburg Pincus Partners II, L.P. | Dir, 10% | S - Sale | $15.27 | -15.00M | 19.10M | -44% | -$229.05M |
| I | 2026-03-10 | 2026-03-06 | SHC | Warburg Pincus Partners GP LLC | Dir, 10% | S - Sale | $15.27 | -15.00M | 19.10M | -44% | -$229.05M |
| I | 2026-03-10 | 2026-03-06 | SHC | GTCR CO-INVEST XI LP | Dir, 10% | S - Sale | $15.27 | -10.00M | 12.74M | -44% | -$152.70M |
| D | 2026-03-04 | 2026-03-02 | SHC | Rutz Michael P | Pres of Sterigenics | A - Grant | $0.00 | +45.2K | 484.3K | +10% | $0 |
| DM | 2026-03-04 | 2026-03-02 | SHC | Rutz Michael P | Pres of Sterigenics | F - Tax | $15.91 | -25.7K | 442.0K | -5% | -$409.2K |
| D | 2026-03-04 | 2026-03-02 | SHC | Rutz Michael P | Pres of Sterigenics | M - OptEx | — | +14.6K | 456.6K | +3% | — |
| DM | 2026-03-04 | 2026-03-02 | SHC | DIMITRIEF ALEXANDER | SVP, GC, Sec | F - Tax | $15.91 | -31.6K | 320.0K | -9% | -$502.1K |
| D | 2026-03-04 | 2026-03-02 | SHC | DIMITRIEF ALEXANDER | SVP, GC, Sec | M - OptEx | — | +16.8K | 343.6K | +5% | — |
| DM | 2026-03-04 | 2026-03-02 | SHC | Petras Michael B. Jr. | COB, CEO, Dir | F - Tax | $15.91 | -190.3K | 452.2K | -30% | -$3.03M |
| D | 2026-03-04 | 2026-03-02 | SHC | Petras Michael B. Jr. | COB, CEO, Dir | A - Grant | $0.00 | +240.2K | 692.4K | +53% | $0 |
| D | 2026-03-04 | 2026-03-02 | SHC | Petras Michael B. Jr. | COB, CEO, Dir | M - OptEx | — | +89.7K | 570.8K | +19% | — |
| DM | 2026-03-04 | 2026-03-02 | SHC | Lyons Jonathan M. | CFO, Sr. VP | F - Tax | $15.91 | -38.3K | 177.5K | -18% | -$608.9K |
| D | 2026-03-04 | 2026-03-02 | SHC | Lyons Jonathan M. | CFO, Sr. VP | M - OptEx | — | +17.9K | 201.5K | +10% | — |
| D | 2026-03-04 | 2026-03-02 | SHC | Lyons Jonathan M. | CFO, Sr. VP | A - Grant | $0.00 | +59.4K | 228.6K | +35% | $0 |
| 2025-12-10 | 2025-12-08 | SHC | Petras Michael B. Jr. | COB, CEO, Dir | S - Sale | $16.45 | -315.9K | 552.8K | -36% | -$5.20M | |
| MI | 2025-12-10 | 2025-12-08 | SHC | Petras Michael B. Jr. | COB, CEO, Dir | S - Sale | $16.45 | -434.1K | 0 | -100% | -$7.14M |
| I | 2025-12-05 | 2025-12-03 | SHC | Warburg Pincus Partners GP LLC | Dir, 10% | S - Sale | $16.33 | -9.72M | 34.10M | -22% | -$158.73M |
| I | 2025-12-05 | 2025-12-03 | SHC | WARBURG PINCUS LLC | Dir, 10% | S - Sale | $16.33 | -9.72M | 34.10M | -22% | -$158.73M |
| I | 2025-12-05 | 2025-12-03 | SHC | GTCR FUND XI/A LP | Dir, 10% | S - Sale | $16.33 | -6.48M | 22.74M | -22% | -$105.82M |
| I | 2025-11-12 | 2025-11-10 | SHC | Warburg Pincus Partners II, L.P. | Dir | S - Sale | $15.65 | -18.00M | 43.82M | -29% | -$281.70M |
| I | 2025-11-12 | 2025-11-10 | SHC | GTCR FUND XI/A LP | Dir, 10% | S - Sale | $15.65 | -12.00M | 29.22M | -29% | -$187.80M |
| I | 2025-11-12 | 2025-11-10 | SHC | Warburg Pincus Private Equity XI-C, L.P. | Dir, 10% | S - Sale | $15.65 | -18.00M | 43.82M | -29% | -$281.70M |
| I | 2025-09-09 | 2025-09-05 | SHC | GTCR INVESTMENT XI LLC | Dir, 10% | S - Sale | $15.11 | -8.00M | 41.22M | -16% | -$120.88M |
| I | 2025-09-09 | 2025-09-05 | SHC | WARBURG PINCUS & CO. | Dir, 10% | S - Sale | $15.11 | -12.00M | 61.82M | -16% | -$181.32M |
| I | 2025-09-09 | 2025-09-05 | SHC | Warburg Pincus XI-C, LLC | Dir, 10% | S - Sale | $15.11 | -12.00M | 61.82M | -16% | -$181.32M |
| 2025-08-26 | 2025-08-22 | SHC | Rutz Michael P | Pres of Sterigenics | S - Sale | $16.38 | -126.6K | 450.2K | -22% | -$2.07M | |
| 2025-08-07 | 2025-08-05 | SHC | Lyons Jonathan M. | CFO, Sr. VP | F - Tax | $11.19 | -11.5K | 189.6K | -6% | -$128.8K | |
| 2025-05-27 | 2025-05-22 | SHC | Klee Ann R. | Dir | A - Grant | $0.00 | +19.1K | 126.0K | +18% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | PETRELLA VINCENT K | Dir | A - Grant | $0.00 | +19.1K | 80.8K | +31% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | Knauss Robert Brown | Dir | A - Grant | $0.00 | +19.1K | 54.9K | +53% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | Neary James | Dir | A - Grant | $0.00 | +19.1K | 80.8K | +31% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | MIHAS CONSTANTINE S | Dir | A - Grant | $0.00 | +19.1K | 80.8K | +31% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | Chen Ruoxi | Dir | A - Grant | $0.00 | +19.1K | 80.8K | +31% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | CUNNINGHAM SEAN LAURENCE | Dir | A - Grant | $0.00 | +19.1K | 80.8K | +31% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | Wheadon David E. | Dir | A - Grant | $0.00 | +19.1K | 74.9K | +34% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | Simon, Christopher | Dir | A - Grant | $0.00 | +19.1K | 19.1K | New | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | Flynn Karen | Dir | A - Grant | $0.00 | +19.1K | 39.2K | +95% | $0 | |
| D | 2025-03-04 | 2025-03-02 | SHC | DIMITRIEF ALEXANDER | SVP, GC, Sec | F - Tax | $12.47 | -8,211 | 278.7K | -3% | -$102.4K |
| D | 2025-03-04 | 2025-03-03 | SHC | DIMITRIEF ALEXANDER | SVP, GC, Sec | A - Grant | $0.00 | +56.1K | 334.7K | +20% | $0 |
| D | 2025-03-04 | 2025-03-03 | SHC | Petras Michael B. Jr. | COB, CEO, Dir | A - Grant | $0.00 | +299.0K | 868.6K | +52% | $0 |
| DM | 2025-03-04 | 2025-03-02 | SHC | Petras Michael B. Jr. | COB, CEO, Dir | F - Tax | $12.47 | -100.8K | 642.5K | -14% | -$1.26M |
| DM | 2025-03-04 | 2025-03-02 | SHC | Rutz Michael P | Pres of Sterigenics | F - Tax | $12.47 | -13.3K | 528.2K | -2% | -$165.7K |
| D | 2025-03-04 | 2025-03-03 | SHC | Rutz Michael P | Pres of Sterigenics | A - Grant | $0.00 | +48.6K | 576.8K | +9% | $0 |
| D | 2025-03-04 | 2025-03-02 | SHC | Lyons Jonathan M. | CFO, Sr. VP | F - Tax | $12.47 | -6,481 | 104.0K | -6% | -$80.8K |
| DM | 2025-03-04 | 2025-03-03 | SHC | Lyons Jonathan M. | CFO, Sr. VP | A - Grant | $0.00 | +97.2K | 201.1K | +93% | $0 |
| 2024-11-22 | 2024-11-20 | SHC | Rutz Michael P | Pres of Sterigenics | F - Tax | $13.21 | -2,889 | 541.5K | -0.5% | -$38.2K | |
| 2024-11-22 | 2024-11-20 | SHC | Petras Michael B. Jr. | COB, CEO | F - Tax | $13.21 | -29.2K | 670.5K | -4% | -$386.4K | |
| MI | 2024-11-22 | 2024-11-22 | SHC | Petras Michael B. Jr. | COB, CEO | G - Gift | $0.00 | 0 | 5.21M | New | $0 |
| I | 2024-09-12 | 2024-09-10 | SHC | Petras Michael B. Jr. | COB, CEO | G - Gift | $0.00 | -200.0K | 5.25M | -4% | $0 |
| I | 2024-09-09 | 2024-09-06 | SHC | Bull Holdco L.P. | Dir, 10% | S - Sale | $15.03 | -15.00M | 73.82M | -17% | -$225.45M |
| I | 2024-09-09 | 2024-09-06 | SHC | GTCR PARTNERS XI/A&C LP | Dir, 10% | S - Sale | $15.03 | -10.00M | 49.22M | -17% | -$150.30M |
| I | 2024-09-09 | 2024-09-06 | SHC | Warburg Pincus Private Equity XI-C, L.P. | Dir, 10% | S - Sale | $15.03 | -15.00M | 73.82M | -17% | -$225.45M |
| 2024-08-07 | 2024-08-05 | SHC | Lyons Jonathan M. | CFO, Sr. VP | F - Tax | $14.22 | -7,659 | 110.4K | -6% | -$108.9K | |
| 2024-05-29 | 2024-05-24 | SHC | Wheadon David E. | Dir | A - Grant | $0.00 | +20.1K | 55.8K | +56% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | Klee Ann R. | Dir | A - Grant | $0.00 | +20.1K | 106.8K | +23% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | Flynn Karen | Dir | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | Chen Ruoxi | Dir | A - Grant | $0.00 | +20.1K | 61.6K | +48% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | MIHAS CONSTANTINE S | Dir | A - Grant | $0.00 | +20.1K | 61.6K | +48% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | Knauss Robert Brown | Dir | A - Grant | $0.00 | +20.1K | 35.8K | +128% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | Donnini David | Dir | A - Grant | $0.00 | +20.1K | 61.6K | +48% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | PETRELLA VINCENT K | Dir | A - Grant | $0.00 | +20.1K | 61.6K | +48% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | CUNNINGHAM SEAN LAURENCE | Dir | A - Grant | $0.00 | +20.1K | 61.6K | +48% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | Neary James | Dir | A - Grant | $0.00 | +20.1K | 61.6K | +48% | $0 | |
| I | 2024-03-06 | 2024-03-04 | SHC | GTCR PARTNERS XI/A&C LP | Dir, 10% | S - Sale | $14.31 | -11.06M | 59.22M | -16% | -$158.31M |
| 2024-03-06 | 2024-03-04 | SHC | Klee Ann R. | Dir | S - Sale | $14.31 | -5,750 | 86.7K | -6% | -$82.3K | |
| D | 2024-03-06 | 2024-03-04 | SHC | Lyons Jonathan M. | CFO, Sr. VP | A - Grant | $0.00 | +41.1K | 118.1K | +53% | $0 |
| I | 2024-03-06 | 2024-03-04 | SHC | WARBURG PINCUS & CO. | Dir, 10% | S - Sale | $14.31 | -16.59M | 88.82M | -16% | -$237.47M |
| I | 2024-03-06 | 2024-03-04 | SHC | WP Global LLC | Dir, 10% | S - Sale | $14.31 | -16.59M | 88.82M | -16% | -$237.47M |
| D | 2024-03-06 | 2024-03-04 | SHC | DIMITRIEF ALEXANDER | SVP, GC, Sec | A - Grant | $0.00 | +51.4K | 286.9K | +22% | $0 |
| DM | 2024-03-05 | 2024-03-02 | SHC | Petras Michael B. Jr. | COB, CEO | F - Tax | $14.56 | -49.6K | 425.6K | -10% | -$721.7K |
| DI | 2024-03-05 | 2024-03-04 | SHC | Petras Michael B. Jr. | COB, CEO | S - Sale | $14.31 | -1.00M | 5.45M | -16% | -$14.37M |
| D | 2024-03-05 | 2024-03-04 | SHC | Petras Michael B. Jr. | COB, CEO | A - Grant | $0.00 | +274.2K | 699.7K | +64% | $0 |
| D | 2024-03-05 | 2024-03-04 | SHC | Rutz Michael P | Pres of Sterigenics | A - Grant | $0.00 | +34.3K | 627.5K | +6% | $0 |
| DM | 2024-03-05 | 2024-03-02 | SHC | Rutz Michael P | Pres of Sterigenics | F - Tax | $14.56 | -5,501 | 596.3K | -0.9% | -$80.1K |
| D | 2024-03-05 | 2024-03-04 | SHC | Rutz Michael P | Pres of Sterigenics | S - Sale | $14.31 | -83.1K | 544.4K | -13% | -$1.19M |
| 2023-11-22 | 2023-11-20 | SHC | Rutz Michael P | Pres of Sterigenics | F - Tax | $13.93 | -1,911 | 598.7K | -0.3% | -$26.6K | |
| 2023-11-22 | 2023-11-20 | SHC | Petras Michael B. Jr. | COB, CEO, Dir | F - Tax | $13.93 | -29.2K | 555.4K | -5% | -$407.5K | |
| D | 2023-08-09 | 2023-08-07 | SHC | Lyons Jonathan M. | CFO, Sr. VP | A - Grant | $0.00 | +77.0K | 77.0K | New | $0 |
| 2023-05-31 | 2023-05-26 | SHC | Chen Ruoxi | Dir | A - Grant | $0.00 | +15.7K | 41.6K | +61% | $0 | |
| 2023-05-31 | 2023-05-26 | SHC | Neary James | Dir | A - Grant | $0.00 | +15.7K | 41.6K | +61% | $0 | |
| 2023-05-31 | 2023-05-26 | SHC | PETRELLA VINCENT K | Dir | A - Grant | $0.00 | +15.7K | 41.6K | +61% | $0 |
Purchase Sale Sale after option exercise All abbreviations